Overview
Kun-ming Ming-Chan practices practicing medicine in Taoyuan, Taiwan.
Their clinical expertise encompasses Liver Cancer, Colorectal Cancer, Hepatectomy, and Liver Transplant.
They are actively involved in clinical research, co-authoring 9 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Kun-ming Ming-Chan
Is Kun-ming Ming-Chan a top-rated expert for Hepatectomy?
MediFind is an objective health platform that identifies experts based on real-world data. Kun-ming Ming-Chan is classified as an Experienced expert for Hepatectomy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Kun-ming Ming-Chan participate in research or clinical trials?
Yes. Kun-ming Ming-Chan has published 9 articles and abstracts on conditions like Hepatectomy. You can view a list of Kun-ming Ming-Chan's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Colorectal CancerMing-Chan isExperienced. Learn about Colorectal Cancer.
- HepatectomyMing-Chan isExperienced. Learn about Hepatectomy.
- Liver CancerMing-Chan isExperienced. Learn about Liver Cancer.
- Liver TransplantMing-Chan isExperienced. Learn about Liver Transplant.